The most common mode of failure observed in cemented orthopaedic implants is aseptic loosening of the prosthesis over time. This occurs as a result of fatigue failure of the bone cement under different loading conditions. Although a great deal of research has been carried out on the fatigue crack development of poly(methyl methacrylate) (PMMA) bone cements, the effects of different loading frequencies at low and high stress intensities are not well understood. Therefore, the aims of this study are to determine the effects of loading PMMA bone cement at different stress intensities and loading frequencies, as seen in-vivo, and the effects of changing these parameters on fatigue crack propagation. To achieve these aims, disc compact tension (DCT) samples with chevron notches were made and Krak Gages (Russenberger Prufmaschinen, Neuhausen am Rheinfall, Switzerland) were attached to monitor crack growth. The bone cement used in this study was the Cemex System, which uses a cement gun to mix and apply the material into the cavity. From standard compression and bending tests it was found that the cement made using this system had an average compressive strength of 86.66±5.52MPa, an average bending modulus of 3696.06±121.13MPa and an average bending strength of 51.95±4.14MPa. These values are within the normal range of acrylic resin cements for implants and above the minimum requirements of the ISO5833:2002 standard. A program has been written that loads the DCT samples with a stress intensity of 0.2MPam. 1/2. , 0.6MPam. 1/2. and 1.0MPam. 1/2. at a frequency of 1Hz, 2Hz, 5Hz, 10Hz and 20Hz. The crack was allowed to grow 0.2mm at each frequency and the frequencies were increased (1Hz to 20Hz) then decreased in magnitude (20Hz to 1Hz) for each of the stress intensities. This experimental design enables much more sensitive detection of small changes in crack growth rate than a conventional test where the crack grows through the entire range of δK at a single frequency. By repeatedly varying the loading within the same specimen the effects of variation between specimens can be removed, revealing significant differences in crack growth rate. The results provide important information on bone cement when loaded in conditions similar to those seen in-vivo and how frequency and stress intensities affect the fracture mechanics of PMMA

The discussion will focus on new approaches to reduce bacterial adhesion on the surface of polymethylmethacrylate (PMMA) in contact with bone, comparing the clinical and engineering point of view. One possibility is to encourage and speed up direct interaction with the bone, for example by adding a bioactive phase in the cement (hydroxyapatite, glass and bioactive glass ceramic). A widespread strategy is also the addition of different types of antibiotics (gentamicin, tobramycin vancomycin, etc.), although they are known to have some drawbacks: not complete release, resistant strain development. Another strategy could be represented by the PMMA-based composite cements loaded with a completely inorganic filler consisting of a bioactive glass doped with ions whose bioactivity mechanism is well-known and encompasses a chemical and biological interaction with tissues promoting osteoinduction. Bioactive glasses can be doped with antibacterial ions (silver, copper, etc.) preserving their biocompatibility and bioactivity and, at the same time, acquiring antibacterial properties. Thus, it is possible to produce composite cements that combine the properties of the polymer matrix with those of the inorganic filler, overcoming the main problems associated with the use of antibiotics. An additional possibility is the addition of essential oils, vegetable oils with remarkable antibacterial properties.

Objectives

Vancomycin and fosfomycin are antibiotics commonly used to treat methicillin-resistant Staphylococcus aureus (MRSA) infection. This study compares the in vitro inhibitory effects against MRSA of articulating cement spacers impregnated with either vancomycin or fosfomycin.